Algernon Pharmaceuticals Inc (AGNPF)
0.082
0.00 (0.00%)
USD |
OTCM |
Jun 28, 16:00
Algernon Pharmaceuticals Shareholders Equity (Quarterly): 3.265M for Nov. 30, 2022
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| November 30, 2022 | 3.265M |
| August 31, 2022 | 4.296M |
| May 31, 2022 | 4.390M |
| February 28, 2022 | 4.971M |
| November 30, 2021 | 6.194M |
| August 31, 2021 | 7.228M |
| May 31, 2021 | 8.052M |
| February 28, 2021 | 7.244M |
| November 30, 2020 | 7.011M |
| August 31, 2020 | 9.338M |
| May 31, 2020 | 9.622M |
| February 29, 2020 | 5.579M |
| November 30, 2019 | 4.875M |
| August 31, 2019 | 3.721M |
| May 31, 2019 | 3.993M |
| Date | Value |
|---|---|
| February 28, 2019 | 4.510M |
| November 30, 2018 | 4.689M |
| August 31, 2018 | 1.052M |
| May 31, 2018 | 1.131M |
| February 28, 2018 | 1.271M |
| November 30, 2017 | 1.087M |
| August 31, 2017 | 1.259M |
| May 31, 2017 | 1.401M |
| February 28, 2017 | 1.966M |
| November 30, 2016 | 2.175M |
| August 31, 2016 | 1.622M |
| May 31, 2016 | 1.966M |
| February 29, 2016 | 1.892M |
| November 30, 2015 | 2.060M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
3.265M
Minimum
Nov 2022
9.622M
Maximum
May 2020
6.128M
Average
5.887M
Median
Shareholders Equity (Quarterly) Benchmarks
| Acasti Pharma Inc | 61.74M |
| Aurinia Pharmaceuticals Inc | 377.95M |
| Edesa Biotech Inc | 4.324M |
| Lexaria Bioscience Corp | 6.521M |
| Xenon Pharmaceuticals Inc | 887.70M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 4.912M |
| Total Liabilities (Quarterly) | 1.647M |